Notes on cancer medications and the ridiculous tariffs.
#Cancer #tRumpTariffs #CancerMedication #Lenvima #MedicalCosts #tariffs
#Cancer #tRumpTariffs #CancerMedication #Lenvima #MedicalCosts #tariffs
September 26, 2025 at 9:37 PM
Notes on cancer medications and the ridiculous tariffs.
#Cancer #tRumpTariffs #CancerMedication #Lenvima #MedicalCosts #tariffs
#Cancer #tRumpTariffs #CancerMedication #Lenvima #MedicalCosts #tariffs
Moi, j’ai commencé le Lenvima (à vie 😞) en traitement de confort. Je me garde le choix de l’arrêter si ça enlève sur ma qualité de vie restante.
Tellement contente pour toi!!! 🥹
Tellement contente pour toi!!! 🥹
August 13, 2026 at 8:04 PM
Moi, j’ai commencé le Lenvima (à vie 😞) en traitement de confort. Je me garde le choix de l’arrêter si ça enlève sur ma qualité de vie restante.
Tellement contente pour toi!!! 🥹
Tellement contente pour toi!!! 🥹
Well, my suspicion was correct: I am to stay on the Keytruda & Lenvima until either I have a recurrence or can no longer tolerate the side effects. Bleh. How is chocolate not tasting right a tolerable side effect? I’m not good with open- ended timelines. #cansky #oncosky
February 15, 2025 at 2:57 AM
Whew! My latest PET scan shows no evidence of disease! My previous scans 3 months ago were inconclusive due to a lot of inflammation, But 3 months off the Keytruda/Lenvima combo, it’s resolved! I get 3 more months without tests, scans or visits! #cansky #oncosky #endometrialcancer
February 20, 2026 at 9:25 PM
Whew! My latest PET scan shows no evidence of disease! My previous scans 3 months ago were inconclusive due to a lot of inflammation, But 3 months off the Keytruda/Lenvima combo, it’s resolved! I get 3 more months without tests, scans or visits! #cansky #oncosky #endometrialcancer
Vielleicht werd ich alt, aber ich komm bei diesen ganzen neuen Pokemon nicht mehr mit.
![[...] AOK Nordost. Man kann sich vorstellen, welchen finanziellen Schaden Rezeptfälscher der Gesamtgemeinschaft der gesetzlich Krankenversicherten jährlich zufügen.“ Die größten finanziellen Verluste sind auf Fälschungen von Alecensa, Braftovi, Caprelsa, Fentanyl, Lenvima, Lonsurf, Mekinist, Mektovi, Mounjaro, Orserdu, Ozempic, Ragwizax und Tukysa zurückzuführen.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:5lktscfkgkg7kek57czn74pc/bafkreiawg6jvvs6aorfzgfxz4bdciudpilarwuuew3vvb7u7fpmf2mmobe)
December 20, 2025 at 11:33 PM
Vielleicht werd ich alt, aber ich komm bei diesen ganzen neuen Pokemon nicht mehr mit.
My second day of a one-month break from Lenvima in advance of an overseas trip. I’m hoping I can actually taste & tolerate food while I’m traveling. I’ve been on Lenvima for 10 months & it’s been wreaking havoc on my entire GI system. 🤞🏻#cansky #oncosky
September 18, 2025 at 3:06 PM
My second day of a one-month break from Lenvima in advance of an overseas trip. I’m hoping I can actually taste & tolerate food while I’m traveling. I’ve been on Lenvima for 10 months & it’s been wreaking havoc on my entire GI system. 🤞🏻#cansky #oncosky
Cancer treatment is so weird. Due to side effects from Lenvima, I’ve lost almost 30 lbs since Nov. Nutritionist: “You need dense calories. Eat fat. Bacon, butter, cheese, olive oil. Drizzle a tablespoon of olive oil over your bowl of soup - that’s 100 more calories right there.” #cansky #oncosky
April 13, 2025 at 6:05 PM
Good news! My oncologist confirmed that the spot on my lung that lit up on my PET scan two weeks ago was probably nothing as the subsequent diagnostic CT scan did not show any nodule in that location. So I’m cleared for my upcoming travel with a one month break from Lenvima! #cansky #oncosky #oncsky
August 21, 2025 at 4:33 PM
Good news! My oncologist confirmed that the spot on my lung that lit up on my PET scan two weeks ago was probably nothing as the subsequent diagnostic CT scan did not show any nodule in that location. So I’m cleared for my upcoming travel with a one month break from Lenvima! #cansky #oncosky #oncsky
Currently taking Lenvima @ $26,091 per month and Keytruda infusion @ $11,780 every 3 weeks. If I lose my ACA insurance, I guess my choices are leave the country or die. 😑
Disgusting and infuriating.
Disgusting and infuriating.
May 14, 2025 at 9:10 AM
Currently taking Lenvima @ $26,091 per month and Keytruda infusion @ $11,780 every 3 weeks. If I lose my ACA insurance, I guess my choices are leave the country or die. 😑
Disgusting and infuriating.
Disgusting and infuriating.
FDA approved Belzutifan + Lenvatinib for advanced kidney cancer after immunotherapy. In a trial (747 pts), it extended time before cancer worsened to 14.6 vs 10.6 months. What does an extra 4 months of stable disease truly mean for these patients?
FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Kidney Cancer Post-Immunotherapy
The U.S. Food and Drug Administration (FDA) has approved a new combination treatment consisting of belzutifan (Welireg) and lenvatinib (Lenvima) for adults battling advanced renal cell carcinoma, a ty
www.fda.gov
September 25, 2026 at 8:02 AM
FDA approved Belzutifan + Lenvatinib for advanced kidney cancer after immunotherapy. In a trial (747 pts), it extended time before cancer worsened to 14.6 vs 10.6 months. What does an extra 4 months of stable disease truly mean for these patients?
This weekend we're reading about Keytruda and Lenvima. Trying to guess which side effects to prepare for. Jay's happy he might get to keep his hair and I desperately want him to shave it!
March 22, 2026 at 6:01 AM
This weekend we're reading about Keytruda and Lenvima. Trying to guess which side effects to prepare for. Jay's happy he might get to keep his hair and I desperately want him to shave it!
Kidney cancer progressed after immunotherapy? 🧬
FDA approved belzutifan (Welireg®) + lenvatinib (Lenvima®) on Sept 28 for advanced clear cell RCC after PD-1/PD-L1 therapy: the first HIF-2α inhibitor + VEGFR-TKI combo for these patients.
#KidneyCancer #RCC #Oncology #ChinaOnlinePharmacy
FDA approved belzutifan (Welireg®) + lenvatinib (Lenvima®) on Sept 28 for advanced clear cell RCC after PD-1/PD-L1 therapy: the first HIF-2α inhibitor + VEGFR-TKI combo for these patients.
#KidneyCancer #RCC #Oncology #ChinaOnlinePharmacy
September 30, 2026 at 7:48 AM
Kidney cancer progressed after immunotherapy? 🧬
FDA approved belzutifan (Welireg®) + lenvatinib (Lenvima®) on Sept 28 for advanced clear cell RCC after PD-1/PD-L1 therapy: the first HIF-2α inhibitor + VEGFR-TKI combo for these patients.
#KidneyCancer #RCC #Oncology #ChinaOnlinePharmacy
FDA approved belzutifan (Welireg®) + lenvatinib (Lenvima®) on Sept 28 for advanced clear cell RCC after PD-1/PD-L1 therapy: the first HIF-2α inhibitor + VEGFR-TKI combo for these patients.
#KidneyCancer #RCC #Oncology #ChinaOnlinePharmacy
The company is going to provide a year of Lenvima at no cost!
#FrightClub
Wait... does this mean I have to stop shit talking drug companies?
#FrightClub
Wait... does this mean I have to stop shit talking drug companies?
a man and a woman are jumping in the air in a living room .
ALT: a man and a woman are jumping in the air in a living room .
media.tenor.com
April 2, 2026 at 5:01 PM
The company is going to provide a year of Lenvima at no cost!
#FrightClub
Wait... does this mean I have to stop shit talking drug companies?
#FrightClub
Wait... does this mean I have to stop shit talking drug companies?
Well, the 20 mg daily dose of Lenvima didn’t last long (17 days) Apparently my liver is not happy with the stuff (neither is my sore mouth). Dose reduced to 10 mg/day. Doc said to call if my eyes turn yellow. I guess I know what color I’ll be using in my next art piece. #cansky #oncosky #cancerbs
December 4, 2024 at 6:43 PM
After an anxious 2 days, I got my latest PET scan results yesterday. No evidence of new or residual disease! That makes 8 months since my brachytherapy & the addition of Lenvima along with the Keytruda. One unidentifiable new spot in my right lung. But I won’t worry about it until we have more info.
August 1, 2025 at 2:58 PM
After an anxious 2 days, I got my latest PET scan results yesterday. No evidence of new or residual disease! That makes 8 months since my brachytherapy & the addition of Lenvima along with the Keytruda. One unidentifiable new spot in my right lung. But I won’t worry about it until we have more info.
Endometrial cancer here. I was in active treatment almost all of 2025 (off Keytruda/Lenvima since September until my next scan in Feb). The amount of damage these life-saving meds inflicted on my body is staggering. Here’s to more recovery in 2026!
December 31, 2025 at 10:05 PM
Endometrial cancer here. I was in active treatment almost all of 2025 (off Keytruda/Lenvima since September until my next scan in Feb). The amount of damage these life-saving meds inflicted on my body is staggering. Here’s to more recovery in 2026!
NEWS: A US court has handed an important patent victory to Eisai and MSD for their cancer blockbuster Lenvima.
pharmaphorum.com/news/eisai-s...
pharmaphorum.com/news/eisai-s...
Eisai says patent win blocks Lenvima generic to 2036
Eisai has won a lawsuit blocking FDA approval of Shilpa's generic of cancer blockbuster Lenvima until 2036, although the verdict could go to appeal
pharmaphorum.com
May 29, 2025 at 10:03 AM
NEWS: A US court has handed an important patent victory to Eisai and MSD for their cancer blockbuster Lenvima.
pharmaphorum.com/news/eisai-s...
pharmaphorum.com/news/eisai-s...
Thoughts on this? >> Merck and Eisai reveal late-stage fail for Keytruda and
Lenvima in gastroesophageal cancer: The combination of Merck’s Keytruda and Eisai’s Lenvima… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #pharmaceutical #biotech
Lenvima in gastroesophageal cancer: The combination of Merck’s Keytruda and Eisai’s Lenvima… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #pharmaceutical #biotech
Merck and Eisai reveal late-stage fail for Keytruda and
Lenvima in gastroesophageal cancer
The combination of Merck’s Keytruda and Eisai’s Lenvima failed to prolong patients’ lives versus the comparator in another cancer study, but the companies say they are committed to the approach. In the Phase 3 trial ...
dlvr.it
January 24, 2025 at 9:12 PM
Thoughts on this? >> Merck and Eisai reveal late-stage fail for Keytruda and
Lenvima in gastroesophageal cancer: The combination of Merck’s Keytruda and Eisai’s Lenvima… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #pharmaceutical #biotech
Lenvima in gastroesophageal cancer: The combination of Merck’s Keytruda and Eisai’s Lenvima… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #pharmaceutical #biotech
Hi. Just searched Lenvima on here and your posts came up. I’m also on Keytruda/Lenvima for my 2nd recurrence of Uterine cancer. I have two tumors in my abdomen currently. Been in treatment since 2020 - failed taxol/carbo.
March 11, 2025 at 6:15 PM
Hi. Just searched Lenvima on here and your posts came up. I’m also on Keytruda/Lenvima for my 2nd recurrence of Uterine cancer. I have two tumors in my abdomen currently. Been in treatment since 2020 - failed taxol/carbo.
FDA、進行性透明細胞型腎細胞がんにベルズチファンとレンバチニブ併用療法を承認
FDAは2026年9月、PD-1またはPD-L1阻害剤治療後に疾患が進行した進行性透明細胞型腎細胞がん（ccRCC）の成人患者に対し、ベルズチファン（Welireg）とレンバチニブ（Lenvima）の併用療法を承認した。この承認は、カボザンチニブ（Cabometyx）に対する優越性を示した第3相LITESPARK-011試験（NCT04586231）の結果に基づいている。
出典: urologytimes.com
FDAは2026年9月、PD-1またはPD-L1阻害剤治療後に疾患が進行した進行性透明細胞型腎細胞がん（ccRCC）の成人患者に対し、ベルズチファン（Welireg）とレンバチニブ（Lenvima）の併用療法を承認した。この承認は、カボザンチニブ（Cabometyx）に対する優越性を示した第3相LITESPARK-011試験（NCT04586231）の結果に基づいている。
出典: urologytimes.com
FDA、進行性透明細胞型腎細胞がんにベルズチファンとレンバチニブ併用療法を承認
FDAは2026年9月、PD-1またはPD-L1阻害剤治療後に疾患が進行した進行性透明細胞型腎細胞がん（ccRCC）の成人患者に対し、ベルズチファン（Welireg）とレンバチニブ（Lenvima）の併用療法を承認した。この承認は、カボザンチニブ（Cabometyx）に対する優越性を示した第3相LITESPARK-011試験（NCT04586231）の結果に基づいている。試験では747人の患者がラ
www.urologytimes.com
October 1, 2026 at 8:10 AM
FDA、進行性透明細胞型腎細胞がんにベルズチファンとレンバチニブ併用療法を承認
FDAは2026年9月、PD-1またはPD-L1阻害剤治療後に疾患が進行した進行性透明細胞型腎細胞がん（ccRCC）の成人患者に対し、ベルズチファン（Welireg）とレンバチニブ（Lenvima）の併用療法を承認した。この承認は、カボザンチニブ（Cabometyx）に対する優越性を示した第3相LITESPARK-011試験（NCT04586231）の結果に基づいている。
出典: urologytimes.com
FDAは2026年9月、PD-1またはPD-L1阻害剤治療後に疾患が進行した進行性透明細胞型腎細胞がん（ccRCC）の成人患者に対し、ベルズチファン（Welireg）とレンバチニブ（Lenvima）の併用療法を承認した。この承認は、カボザンチニブ（Cabometyx）に対する優越性を示した第3相LITESPARK-011試験（NCT04586231）の結果に基づいている。
出典: urologytimes.com
✨#ESMO25✨
🚨BREAKING: KEYTRUDA® (pembrolizumab) + LENVIMA® (lenvatinib) in Advanced Endometrial Carcinoma
📈 Durable Benefit: 5-year OS results in the pMMR subgroup are consistent with the overall population.
💡 Improved Outcomes: OS rate of 19.9% with KEYTRUDA + LENVIMA vs. 7.7% with chemotherapy.
🚨BREAKING: KEYTRUDA® (pembrolizumab) + LENVIMA® (lenvatinib) in Advanced Endometrial Carcinoma
📈 Durable Benefit: 5-year OS results in the pMMR subgroup are consistent with the overall population.
💡 Improved Outcomes: OS rate of 19.9% with KEYTRUDA + LENVIMA vs. 7.7% with chemotherapy.
October 19, 2025 at 3:00 PM
✨#ESMO25✨
🚨BREAKING: KEYTRUDA® (pembrolizumab) + LENVIMA® (lenvatinib) in Advanced Endometrial Carcinoma
📈 Durable Benefit: 5-year OS results in the pMMR subgroup are consistent with the overall population.
💡 Improved Outcomes: OS rate of 19.9% with KEYTRUDA + LENVIMA vs. 7.7% with chemotherapy.
🚨BREAKING: KEYTRUDA® (pembrolizumab) + LENVIMA® (lenvatinib) in Advanced Endometrial Carcinoma
📈 Durable Benefit: 5-year OS results in the pMMR subgroup are consistent with the overall population.
💡 Improved Outcomes: OS rate of 19.9% with KEYTRUDA + LENVIMA vs. 7.7% with chemotherapy.
This! I have OM from Lenvima. Today, my tongue is on fire. My oncologist’s response: “It’s a known side effect, here’s a mouth rinse.” (Which does nothing.) I’ve lost 25 lbs because eating is painful & my options for food that doesn’t hurt are limited. Hopefully a nutritionist can help.
April 1, 2025 at 7:15 PM
This! I have OM from Lenvima. Today, my tongue is on fire. My oncologist’s response: “It’s a known side effect, here’s a mouth rinse.” (Which does nothing.) I’ve lost 25 lbs because eating is painful & my options for food that doesn’t hurt are limited. Hopefully a nutritionist can help.